Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 28, 2016; 22(44): 9803-9812
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9803
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9803
Metastatic lymph nodes | Total | P value | |||
No amplification | Amplification | ||||
FGFR1 Primary tumor | No amplification | 42 (91.3) | 3 (6.7) | 45 (100) | < 0.001 |
Amplification | 4 (36.4) | 7 (63.6) | 11 (100) | ||
Total | 46 (82.1) | 10 (17.9) | 56 (100) | ||
MYC Primary tumor | No amplification | 17 (63.0) | 10 (37.0) | 27 (100) | 1.000 |
Amplification | 12 (60.0) | 8 (40.0) | 20 (100) | ||
Total | 29 (61.7) | 18 (38.3) | 47 (100) |
- Citation: Kwon D, Yun JY, Keam B, Kim YT, Jeon YK. Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma. World J Gastroenterol 2016; 22(44): 9803-9812
- URL: https://www.wjgnet.com/1007-9327/full/v22/i44/9803.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i44.9803